-
1Academic Journal
Συγγραφείς: О. В. Станько, Р. Э. Якубцевич, А. А. Балла, А. В. Дубровщик
Πηγή: Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, Vol 21, Iss 4, Pp 327-336 (2023)
Θεματικοί όροι: катетер-ассоциированная инфекция кровотока, центральный венозный катетер, биопленки, антисептик, противомикробные препараты, цитрат, этанол, гепарин, Medicine
Περιγραφή αρχείου: electronic resource
Relation: http://journal-grsmu.by/index.php/ojs/article/view/3065; https://doaj.org/toc/2221-8785; https://doaj.org/toc/2413-0109
Σύνδεσμος πρόσβασης: https://doaj.org/article/4491550b947c438d8d24202a2bd6e3c5
-
2Academic Journal
Συγγραφείς: Strokan, A.M., Subbotin, V.Yu.
Πηγή: МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16, № 2 (2020); 111-114
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16, № 2 (2020); 111-114
EMERGENCY MEDICINE; Том 16, № 2 (2020); 111-114Θεματικοί όροι: центральный венозный катетер, периферически установленный центральный катетер, онкогематологические заболевания, 03 medical and health sciences, центральний венозний катетер, периферично встановлений центральний катетер, онкогематологічні захворювання, central venous catheter, peripherally inserted central catheter, oncohematological diseases, 0302 clinical medicine, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://emergency.zaslavsky.com.ua/article/view/203155
-
3Academic Journal
Συγγραφείς: M. A. Leontiev, S. V. Kravchuk, A. V. Vodova, М. А. Леонтьев, С. В. Кравчук, А. В. Водова
Συνεισφορές: The study has no sponsorship, Исследование не имеет спонсорской поддержки
Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 1 (2022); 59-66 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 1 (2022); 59-66 ; 2541-8017 ; 2223-9022
Θεματικοί όροι: педиатрия, catheterization of the subclavian vein, central venous catheter, ultrasound guidance, supraclavicular access, pediatrics, катетеризация подключичной вены, центральный венозный катетер, ультразвуковая навигация, надключичный доступ
Περιγραφή αρχείου: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/1340/1087; https://www.jnmp.ru/jour/article/view/1340/1134; Bansal R, Agarwal SK, Tiwari SC, Dash SC. A prospective randomized study to compare ultrasound-guided with nonultrasound-guided double lumen internal jugular catheter insertion as a temporary hemodialysis access. Ren Fail. 2005;27(5):561–564. PMID: 16152994 https://doi.org/10.1080/08860220500199084; Brass P, Hellmich M, Kolodziej L, Schick G, Smith AF. Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization. Cochrane Database Syst Rev. 2015;1(1):CD006962. PMID: 25575244 https://doi.org/10.1002/14651858.CD006962.pub2; Dolu H, Goksu S, Sahin L, Ozen O, Eken L. Comparison of an ultrasound-guided technique versus a landmark-guided technique for internal jugular vein cannulation. J Clin Monit Comput. 2015;29(1):177–182. PMID: 24838550 https://doi.org/10.1007/s10877-014-9585-3; Froehlich CD, Rigby MR, Rosenberg ES, Li R, Roerig P-LJ, Easley KA, et al. Ultrasound-guided central venous catheter placement decreases complications and decreases placement attempts compared with the landmark technique in patients in a pediatric intensive care unit. Crit Care Med. 2009;37(3):1090–1096. PMID: 19237922 https://doi.org/10.1097/CCM.0b013e31819b570e; Shrestha BR, Gautam B. Ultrasound versus the landmark technique: A prospective randomized comparative study of internal jugular vein cannulation in an intensive care unit. J Nepal Med Assoc. 2011;51(2):56–61. PMID: 22916513 https://doi.org/10.31729/jnma.148; Frykholm P, Pikwer A, Hammarskjold F, Larsson AT, Lindgren S, Lindwall R, et al. Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2014;58(5):508–524. PMID: 24593804 https://doi.org/10.1111/aas.12295; Practice Guidelines for Central Venous Access 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2020;132(1):8–43. PMID: 31821240 https://doi.org/10.1097/ALN.0000000000002864; Lamperti M, Biasucci DG, Disma N, Pittiruti M, Breschan C, Vailati D, et al. European Society of Anaesthesiology guidelines on peri-operative use of ultrasound-guided for vascular access (PERSEUS vascular access). Eur J Anaesthesiol. 2020;37(5):344–376. PMID: 32265391 https://doi.org/10.1097/EJA.0000000000001180; Ares G, Hunter CJ. Central venous access in children: Indications, devices, and risks. Curr Opin Pediatr. 2017;29(3):340–346. PMID: 28323667 https://doi.org/10.1097/MOP.0000000000000485; He C, Vieira R, Marin JR. Utility of ultrasound guidance for central venous access in children. Pediatr Emerg Care. 2017;33(5):359–362. PMID: 28471906 https://doi.org/10.1097/PEC.0000000000001124; Milling TJ, Rose J, Briggs WM, Birkhahn R, Gaeta TJ, Bove JJ, et al. Randomized, controlled clinical trial of point-of-care limited ultrasonography assistance of central venous cannulation: The Third Sonography Outcomes Assessment Program (SOAP-3) Trial. Crit Care Med. 2005;33(8):1764–1769. PMID: 16096454 https://doi.org/10.1097/01.ccm.0000171533.92856.e5; De Souza TH, Brandão MB, Nadal JAH, Nogueira RJN. Ultrasound guidance for pediatric central venous catheterization: A meta-analysis. Pediatrics. 2018;142(5):e20181719. PMID: 30361397 https://doi.org/10.1542/peds.2018-1719; Lau CSM, Chamberlain RS. Ultrasound-guided central venous catheter placement increases success rates in pediatric patients: A meta-analysis. Pediatr Res. 2016;80(2):178–184. PMID: 27057741 https://doi.org/10.1038/pr.2016.74; Parienti J-J, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A et al. Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med. 2015;373(13):1220–1229. PMID: 26398070 https://doi.org/10.1056/nejmoa1500964; Breschan C, Platzer M, Jost R, Stettner H, Beyer A-S, Feigl G, et al. Consecutive, prospective case series of a new method for ultrasound-guided supraclavicular approach to the brachiocephalic vein in children. Br J Anaesth. 2011;106(5):732–737. PMID: 21414981 https://doi.org/10.1093/bja/aer031; Gutiérrez GDS, Sánchez JB, Reyes Patiño RD. Acceso central subclavio por vía supraclavicular en anestesia pediátrica: el renacer de una técnica antigua con la ayuda del ultrasonido. Rev Esp Anestesiol Reanim. 2019;66(5):267–276. PMID: 30718017 https://doi.org/10.1016/j.redar.2019.01.001; Habas F, Baleine J, Milési C, Combes C, Didelot M-N, Romano-Bertrand S, et al. Supraclavicular catheterization of the brachiocephalic vein: a way to prevent or reduce catheter maintenance-related complications in children. Eur J Pediatr. 2018;177(3):451–459. PMID: 29322352 https://doi.org/10.1007/s00431-017-3082-x; Merchaoui Z, Lausten-Thomsen U, Pierre F, Laiba M Ben, Le Saché N, Tissieres P. Supraclavicular approach to ultrasound-guided brachiocephalic vein cannulation in children and neonates. Front Pediatr. 2017;5:211. PMID: 29051889 https://doi.org/10.3389/fped.2017.00211; Byon HJ, Lee GW, Lee JH, Park YH, Kim HS, Kim CS, et al. Comparison between ultrasound-guided supraclavicular and infraclavicular approaches for subclavian venous catheterization in children – A randomized trial. Br J Anaesth. 2013;111(5):788–792. PMID: 23756247 https://doi.org/10.1093/bja/aet202; Grebenik CR, Boyce A, Sinclair ME, Evans RD, Mason DG, Martin B. NICE guidelines for central venous catheterization in children. Is the evidence base sufficient? Br J Anaesth. 2004;92(6):827–830. PMID: 15121722 https://doi.org/10.1093/bja/aeh134; https://www.jnmp.ru/jour/article/view/1340
-
4Academic Journal
Συγγραφείς: Lazarev V.V., Linkova T.V., Negoda P.M., Shutkova A.Y., Gorelikov S.V., Naleyev A.A., Polanskaya M.V., Bykov M.V.
Πηγή: Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care; Vol 11, No 1 (2021); 85-90 ; Российский вестник детской хирургии, анестезиологии и реаниматологии; Vol 11, No 1 (2021); 85-90 ; 2587-6554 ; 2219-4061 ; 10.17816/psaic.20211
Θεματικοί όροι: central venous catheter, long-term venous access, superior vena cava system, superior vena cava aplasia, persistent left superior vena cava, children, центральный венозный катетер, долгосрочный венозный доступ, система верхней полой вены, аплазия верхней полой вены, персистирующая левая верхняя полая вена, дети
Περιγραφή αρχείου: application/pdf
-
5Academic Journal
Συγγραφείς: A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, S. A. Potapkina, N. A. Makatsariya, G. Rizzo, G. C. Di Renzo, D. V. Blinov, L. L. Pankratyeva, V. I. Tsibizova, А. В. Воробьев, В. О. Бицадзе, Д. Х. Хизроева, С. A. Потапкина, Н. А. Макацария, Д. Риццо, Д. К. Ди Ренцо, Д. В. Блинов, Л. Л. Панкратьева, В. И. Цибизова
Πηγή: Obstetrics, Gynecology and Reproduction; Vol 15, No 4 (2021); 390-403 ; Акушерство, Гинекология и Репродукция; Vol 15, No 4 (2021); 390-403 ; 2500-3194 ; 2313-7347
Θεματικοί όροι: профилактика неонатальных тромбозов, risk factors, central venous catheter, von Willebrand factor, vWF, ADAMTS-13, thrombophilia, antiphospholipid antibody circulation, thrombotic microangiopathy, neonatal thrombosis prophylaxis, факторы риска, центральный венозный катетер, фактор фон Виллебранда, тромбофилия, циркуляция антифосфолипидных антител, тромботическая микроангиопатия
Περιγραφή αρχείου: application/pdf
Relation: https://www.gynecology.su/jour/article/view/1066/928; https://www.gynecology.su/jour/article/view/1066/929; Володин Н.Н., Ройтман Е.В., Румянцев А.Г., Шнейдер М.М. Тромбозы у новорожденных: патогенез, диагностика, лечение. Вопросы практической педиатрии. 2012;7(4):34-43.; Saracco P., Bagna R., Gentilomo C. et al.; Neonatal Working Group of the Registro Italiano Trombosi Infantili (RITI). Clinical data of neonatal systemic thrombosis. J Pediatr. 2016;171:60-6.e1. https://doi.org/10.1016/j.jpeds.2015.12.035.; Bhatt M.D., Chan A.K. Venous thrombosis in neonates. Fac Rev. 2021;10:20. https://doi.org/10.12703/r/10-20.; Raffini L., Huang Y.S., Witmer C., Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001-8. https://doi.org/10.1542/peds.2009-0768.; Saxonhouse M.A. Thrombosis in the neonatal intensive care unit. Clin Perinatol. 2015;42(3):651-73. https://doi.org/10.1016/j.clp.2015.04.010.; Saracco P., Parodi E., Fabris C. et al. Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors. Thromb Res. 2009;123(6):805-9. https://doi.org/10.1016/j.thromres.2008.12.002.; Strauss T., Levy-Shraga Y., Ravid B. et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost. 2010;103(2):344-50. https://doi.org/10.1160/TH09-05-0282.; Kenet G., Nowak-Gottl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol. 2012;25(3):333-44. https://doi.org/10.1016/j.beha.2012.07.001.; El-Naggar W., Yoon E.W., McMillan D. et al.; Canadian Neonatal Network Investigators. Epidemiology of thrombosis in Canadian neonatal intensive care units. J Perinatol. 2020;40(7):1083-90. https://doi.org/10.1038/s41372-020-0678-1.; Kenet G., Cohen O., Bajorat T., Nowak-Gottl U. Insights into neonatal thrombosis. Thromb Res. 2019;181(Suppl 1):S33-S36. https://doi.org/10.1016/S0049-3848(19)30364-0.; Haley K.M. Neonatal venous thromboembolism. Front Pediatr. 2017;5:136. https://doi.org/10.3389/fped.2017.00136.; Veldman A., Nord M.F., Michel-Behnke I. Thrombosis in the critically ill neonate: incidence, diagnosis, and management. Vask Health Risk Manag. 2008;4(6):1337-48. https://doi.org/10.2147/vhrm.s4274.; Martin G., Thomas M.A., Wei X.C., Le D. Diffuse intracerebral hemorrhage in an infant with a novel homozygous variant leading to severe protein C deficiency. J Pediatr Hematol Oncol. 2020 Nov 6. https://doi.org/10.1097/MPH.0000000000001993.; Kraus F.T. Fetal thrombotic vasculopathy: perinatal stroke, growth restriction, and other sequelae. Surg Pathol Clin. 2013;6(1):87-100. https://doi.org/10.1016/j.path.2012.10.001.; Young G., Albisetti M., Bonduel M. et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and metaanalysis of observational studies, Circulation. 2008;118(13):1373-82. https://doi.org/10.1161/CIRCULATIONAHA.108.789008.; Monagle P., Ignjatovic V., Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24(2):63-8. https://doi.org/10.1016/j.blre.2009.12.001.; Шабалов Н.П., Иванов Д.О., Шабалова Н.Н. Гемостаз в динамике первой недели жизни как отражение механизмов адаптации к внеутробной жизни новорожденного. Педиатрия. Журнал имени Г.Н. Сперанского. 2000;79(3):22.; Кольцова Е.М., Балашова Е.Н., Пантелеев М.А., Баландина А.Н. Лабораторные аспекты гемостаза новорожденных. Вопросы гематологии/ онкологии и иммунопатологии в педиатрии. 2018;17(4):100-13. https://doi.org/10.24287/1726-1708-2018-17-4-100-113.; Ignjatovic V., Pelkmans L., Kelchtermans H. et al. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults. Thromb Res. 2015;136(6):1303-9. https://doi.org/10.1016/j.thromres.2015.10.034.; Черкасова С.В. Гемостаз новорожденных. Практика педиатра. 2020;(1):49 -52.; Nowak-Gottl U., Limperger V., Kenet G. et al. Developmental hemostasis: a lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cell Mol Dis. 2017;67:2-13. https://doi.org/10.1016/j.bcmd.2016.11.012.; Ignjatovic V. 30 years of developmental haemostasis: what have we learnt and how are we applying this knowledge. Thromb Res. 2018;172:188-9. https://doi.org/10.1016/j.thromres.2018.11.021.; Леонова Е.Ю., Синякин О.Ю. Особенности системы гемостаза у новорожденных детей. Охрана материнства и детства. 2016;(2):76-81.; Strauss T., Sidlik-Muskatel R., Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16(6):301-4. https://doi.org/10.1016/j.siny.2011.07.001.; Wiedmeier S.E., Henry E., Sola-Visner M.C., Christensen R.D. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol. 2009;29(2):130-6. https://doi.org/10.1038/jp.2008.14.; Strauss T., Elisha N., Ravid B. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full-term neonates. Blood Cell Mol Dis. 2017;67:14-7. https://doi.org/10.1016/j.bcmd.2016.12.013.; van Ommen C.H., Sol J.J. Developmental hemostasis and management of central venous catheter thrombosis in neonates. Semin Thromb Hemost. 2016;42(7):752-9. https://doi.org/10.1055/s-0036-1592299.; Sirachainan N., Limrungsikul A., Chuansumrit A. et al. Incidences, risk factors and outcomes of neonatal thromboembolism. J Matern Fetal Neonatal Med. 2018;31(3):347-51. https://doi.org/10.1080/14767058.2017.1285892.; Marquez A., Shabanova V., Faustino E.V.S.; Northeast Pediatric Critical Care Research Consortium. Prediction of catheter-associated thrombosis in critically ill children. Pediatr Crit Care Med. 2016;17(11):e521-e528. https://doi.org/10.1097/PCC.0000000000000958.; Rupp M.E., Karnatak R. Intravascular catheter-related bloodstream infections. Infect Dis Clin North Am. 2018;32(4):765-87. https://doi.org/10.1016/j.idc.2018.06.002.; Thornburg C.D., Smith P.B., Smithwick M.L. et al. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res. 2008;122(6):782-5. https://doi.org/10.1016/j.thromres.2007.10.001.; Amankwah E.K., Atchison C.M., Arlikar S. et al. Risk factors for hospital-associated venous thromboembolism in the neonatal intensive care unit. Thromb Res. 2014;134(2):305-9. https://doi.org/10.1016/j.thromres.2014.05.036.; Andres O., Schulze H., Speer C.P. Platelets in neonates: central mediators in haemostasis, antimicrobial defence and inflammation. Thromb Haemost. 2015;113(1):3-12. https://doi.org/10.1160/TH14-05-0476.; Vorobev A., Makatsariya A., Bitsadze V. et al. Unusual thrombosis or pregnancy complications associated to ovarian cancers: two clinical cases. J Matern Fetal Neonatal Med. 2021;34(9):1430-4. https://doi.org/10.1080/14767058.2019.1638359.; Bhat R., Kumar R., Kwon S. et al. Risk factors for neonatal venous and arterial thromboembolism in the neonatal intensive care unit - a case control study. J Pediatr. 2018;195:28-32. https://doi.org/10.1016/j.jpeds.2017.12.015.; Kulkarni A.A., Osmond M., Bapir M. et al. The effect of labour on the coagulation system in the term neonate. Haemophilia. 2013;19(4):533-8. https://doi.org/10.1111/hae.12115.; Tuckuviene R., Christensen A.L., Helgested J. et al. Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F417-22. https://doi.org/10.1136/archdischild-2011-300665.; Branchford B.R., Mourani P., Bajaj L et al. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012;97(4):509-15. https://doi.org/10.3324/haematol.2011.054775.; Motta M., Rodriguez-Perez C., Tincani A. et al. Neonates born from mothers with autoimmune disorders. Early Hum Dev. 2009;85(10 Suppl):S67-70. https://doi.org/10.1016/j.earlhumdev.2009.08.020.; van Ommen C.H., Nowak-Gottl U. Inherited thrombophilia in pediatric venous thromboembolic disease: why and who to test. Front Pediatr. 2017;5:50. https://doi.org/10.3389/fped.2017.00050.; Sharathkumar A.A., Mahajerin A., Heidt L. et al. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. J Thromb Haemost. 2012;10(7):1326-34. https://doi.org/10.1111/j.1538-7836.2012.04779.x.; Ovesen P.G., Jensen D.M., Damm P. et al. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes: a nationwide study. J Matern Fetal Neonatal Med. 2015;28(14):1720-4. https://doi.org/10.3109/14767058.2014.966677.; Makatsariya A., Bitsadze V., Khizroeva J. et al. Neonatal thrombosis. J Matern Fetal Neonatal Med. 2020 Mar 23:1-9. https://doi.org/10.1080/14767058.2020.1743668. [Online ahead of print].; Kristensen S.R., Kaehne M., Petersen N.E. Hemizygous antithrombindeficiency (Budapest III) in a newborn presenting with a thrombosis at birth. Br J Haematol. 2007;138(3):397-8. https://doi.org/10.1111/j.1365-2141.2007.06662.x.; Monagle P., Chan A.K., Goldenberg N.A. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(Suppl 2):e737S-801S. https://doi.org/10.1378/chest.11-2308.; Limperger V., Klostermeier U.C., Kenet G. et al. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol. 2014;167(3):385-93. https://doi.org/10.1111/bjh.13039.; Lee M.J., Kim K.M., Kim J.S. et al. Long-term survival of a child with homozygous protein C deficiency successfully treated with living donor liver transplantation. Pediatr Transplant. 2009;13(2):251-4. https://doi.org/10.1111/j.1399-3046.2008.00972.x.; Klostermeier U.C., Limperger V., Kenet G. et al. Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Thromb Haemost. 2015;113(2):426-33. https://doi.org/10.1160/TH14-06-0533.; Жарков П.А. Влияние носительства полиморфизмов генов свертывающей системы крови и фолатного обмена на риск развития тромбозов у взрослых и детей. Вопросы практической педиатрии. 2012;7(5):26-32.; Arnaez J., Arca G., Martin-Ancel A., Garcia-Alix A. Coagulation factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T gene mutations do not play a major role in symptomatic neonatal arterial ischaemic stroke. Br J Haematol. 2018;180(2):290-2. https://doi.org/10.1111/bjh.14308.; Kenet G., Lutkhoff L.K., Albisetti M. et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121(16):1838-47. https://doi.org/10.1161/CIRCULATIONAHA.109.913673.; Laugesaar R., Kahre T., Kolk A. et al. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a casecontrol study and two meta-analyses. Acta Paediatr. 2010;99(8):1168-74. https://doi.org/10.1111/j.1651-2227.2010.01784.x.; Turebylu R., Salis R., Erbe R. et al. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol. 2007;27(8):490-5. https://doi.org/10.1038/sj.jp.7211786.; Neshat-Vahid S., Pierce R., Hersey D. et al. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(9):1749-58. https://doi.org/10.1111/jth.13388.; Mekinian A., Lachassinne E., Nicaise-Roland P. et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013;72(2):217-22. https://doi.org/10.1136/annrheumdis-2011-201167.; Berkun Y., Simchen M.J., Strauss T. et al. Antiphospholipid antibodies in neonates with stroke - a unique entity or variant of antiphospholipid syndrome? Lupus. 2014;23(10):986-93. https://doi.org/10.1177/0961203314531842.; Gordon O., Almagor Y., Fridler D. et al. De novo neonatal antiphospholipid syndrome: a case report and review of the literature. Semin Arthritis Rheum. 2014;44(2):241-5. https://doi.org/10.1016/j.semarthrit.2014.04.003.; Fujimura Y., Matsumoto M., Kokame K. et al. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol. 2009;144(5):742-54. https://doi.org/10.1111/j.1365-2141.2008.07515.x.; Strauss T., Elisha N., Ravid B. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2017;67:14-7. https://doi.org/10.1016/j.bcmd.2016.12.013.; Katneni U.K., Ibla J.C., Hunt R. et al. von Willebrand factor/ADAMTS-13 interactions at birth: implications for thrombosis in the neonatal period. J Thromb Haemost. 2019;17(3):429-40. https://doi.org/10.1111/jth.14374.; O'Brien S.H., Kulkarni R., Wallace A. et al. Multicenter dose-finding and efficacy and safety outcomes in neonates and children treated with dalteparin for acute venous thromboembolism. J Thromb Haemost. 2014;12(11):1822-5. https://doi.org/10.1111/jth.12716.; van Ommen C.H., van den Dool E.J., Peters M. Nadroparin therapy in pediatric patients with venous thromboembolic disease. J Pediatr Hematol Oncol. 2008;30(3):230-4. https://doi.org/10.1097/MPH.0b013e31816356f8.; Malowany J.I., Knoppert D.C., Chan A.K. et al. Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Pharmacotherapy. 2007;27(9):1263-71. https://doi.org/10.1592/phco.27.9.1263.; Bauman M.E., Belletrutti M.J., Bajzar L.et al. Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeuticlevels. Thromb Haemost. 2009;101(1):86-92.; Klaassen I.L.M., Sol J.J., Suijker M.H. et al. Are low-molecular-weight heparins safe and effective in children? A systematic review. Blood Rev. 2019;33:33-42. https://doi.org/10.1016/j.blre.2018.06.003.; Witmer C., Raffini L. Treatment of venous thromboembolism in pediatric patients. Blood. 2020;135(5):335-43. https://doi.org/10.1182/blood.2019001847.; Romantsik O., Bruschettini M., Zappettini S. et al. Heparin for the treatment of thrombosis in neonates. Cochrane Database Syst Rev. 2016;11(11):CD012185. https://doi.org/10.1002/14651858.CD012185.pub2.; Monagle P., Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program. 2018;2018(1):399-404. https://doi.org/10.1182/asheducation-2018.1.399.; https://www.gynecology.su/jour/article/view/1066
-
6Academic Journal
Πηγή: Pain, Anaesthesia and Intensive Care; № 4(93) (2020); 71-82
PAIN, ANAESTHESIA & INTENSIVE CARE; № 4(93) (2020); 71-82Θεματικοί όροι: центральный венозный доступ, центральный венозный катетер, катетер-ассоциированная инфекция, 614.23:616 – 089.5:616 – 089.819.1:611.14 (049.5), центральний венозний доступ, центральний венозний катетер, катетер-асоційована інфекція, central venous access, central venous catheter, catheter-associated infection, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://jpaic.aaukr.org/article/view/220688
-
7Academic Journal
Συγγραφείς: A. B. Zulkarnaev, N. M. Fominykh, Z. B. Kardanakhishvili, А. Б. Зулькарнаев, Н. М. Фоминых, З. Б. Карданахишвили
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 21, № 2 (2019); 49-58 ; Вестник трансплантологии и искусственных органов; Том 21, № 2 (2019); 49-58 ; 1995-1191 ; 10.15825/1995-1191-2019-2
Θεματικοί όροι: фактор риска, hemodialysis, arteriovenous fistula, central venous catheter, survival, comorbidity, risk factor, гемодиализ, артериовенозная фистула, центральный венозный катетер, выживаемость, коморбидность
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/1020/802; Arhuidese IJ, Obeid T, Hicks C, Qazi U, Botchey I, Zarkowsky DS et al. Vascular access modifies the protective effect of obesity on survival in hemodialysis patients. Surgery. 2015; 158 (6): 1628-1634. PMID: 26126794. DOI:10.1016/j.surg.2015.04.036.; Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zar-kowsky DS, Qazi U et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015; 150 (5): 441-448. PMID: 25738981. DOI: m.1001/jama-surg.2014.3484.; Zhang JC, Al-Jaishi AA, Na Y, de Sa E, Moist LM. Association between vascular access type and patient mortality among elderly patients on hemodialysis in Canada. HemodialInt. 2014; 18 (3): 616-624. PMID: 24636659. DOI:10.1111/hdi.12151.; Davenport A. Is Hemodialysis Patient Survival Dependent upon Small Solute Clearance (Kt/V)?: If So How Can Kt/V be Adjusted to Prevent Under Dialysis in Vulnerable Groups? Semin Dial. 2017 Mar; 30 (2): 86-92. PMID: 28074616. DOI:10.1111/sdi.12566.; Sun Y, Wang Y, Yu W, Zhuo Y, Yuan Q, Wu X. Association of Dose and Frequency on the Survival of Patients on Maintenance of Hemodialysis in China: A Kaplan-Meier and Cox-Proportional Hazard Model Analysis. Med Sci Monit. 2018 Jul 31; 24: 5329-5337. PMID: 30063696. DOI:10.12659/MSM.909404.; Fang YW, Leu JG, Tsai MH, Liou HH. Higher IntraDialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis. Med Sci Monit. 2019 Jan 24; 25: 691-699. PMID: 30674864. DOI:10.12659/MSM.913137.; Wetmore JB, Li S, Yan H, Xu H, Peng Y, Sinsakul MV et al. Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis. PLoS One. 2018 Sep 26; 13 (9):e0203767. PMID: 30256836. DOI:10.1371/journal.pone.0203767.; Drew DA, Lok CE, Cohen JT, Wagner M, Tangri N, Weiner DE. Vascular access choice in incident hemodialysis patients: a decision analysis. J Am Soc Nephrol. 2015 Jan; 26 (1): 183-191. PMID: 25063436. DOI:10.1681/ASN.2013111236.; Arhuidese IJ, Cooper MA, Rizwan M, Nejim B, Malas MB. Vascular access for hemodialysis in the elderly. J Vasc Surg. 2019 Feb; 69 (2): 517-525.e1. PMID: 30683199. DOI:10.1016/jjvs.2018.05.219.; Томилина НА, Андрусев АМ, Перегудова НГ, Шинкарев МБ. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010-2015 гг. Отчет по данным общероссийского регистра заместительной почечной терапии Российского диализного общества. Часть первая. Нефрология и диализ. 2017; 19 (4, приложение): 1-95. DOI:10.28996/1680-4422-2017-4suppl-1-95.; Ватазин АВ, Зулькарнаев АБ, Фоминых НМ, Карданахишвили ЗБ, Стругайло ЕВ. Формирование и обслуживание сосудистого доступа для хронического гемодиализа в Московской области: пятилетний опыт регионального центра. Вестник трансплантологии и искусственных органов. 2018; 20 (4): 44-53. DOI:10.15825/1995-1191-2018-4-44-53.; Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Amer Geriatr Soc. 1968; 16: 622-626.; Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992; 41:237-48.; Cefalu M. Pointwise confidence intervals for the covariate-adjusted survivor function in the Cox model. The Stata Journal. 2011; 11 (1): 64-81. DOI:10.1177/1536867X1101100104.; Wang B, Wu P, Kwan B, TuXM, Feng C. Simpson’s Paradox: Examples. Shanghai Arch Psychiatry. 2018; 30 (2): 139-143. DOI:10.11919/j.issn.1002-0829.218026.; Alencar de Pinho N, Coscas R, Metzger M, Labeeuw M, Ayav C, Jacquelinet C et al. Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study. BMC Nephrol. 2017; 18 (1): 74. DOI:10.1186/s12882-017-0492-y.; Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006; 47 (3): 469-477.; Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, Mapes D et al. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis. 2009; 53 (5): 804-814. DOI:10.1053/j.ajkd.2008.11.031.; Lacson EJr, Wang W, Lazarus JM, Hakim RM. Change in vascular access and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2009; 54 (5): 912-921. DOI:10.1053/j.ajkd.2009.07.008.; Mehrotra R, Cheung AK, Meyer T, Nath KA. Vascular Access for Hemodialysis and Value-Based Purchasing for ESRD. J Am Soc Nephrol. 2017 Feb; 28 (2): 395397. DOI:10.1681/ASN.2016070769.; Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The Survival Benefit of «Fistula First, Catheter Last» in Hemodialysis Is Primarily Due to Patient Factors. J Am Soc Nephrol. 2017; 28 (2): 645-652. DOI:10.1681/ASN.2016010019.; Woo K, Lok CE. New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients? Clin J Am Soc Nephrol. 2016; 11 (8): 1487-1494. DOI:10.2215/CJN.02190216.; Martmez-Gallardo R, Ferreira-Morong F, Garda-Pi-no G, Cerezo-Arias I, Hernandez-Gallego R, Caravaca F. Congestive heart failure in patients with advanced chronic kidney disease: association with pre-emptive vascular access placement. Nefrologia. 2012; 32 (2): 206-212. DOI:10.3265/Nefrologia.pre2011.Dec.11223.; https://journal.transpl.ru/vtio/article/view/1020
-
8Academic Journal
Συγγραφείς: A. V. Vatazin, A. B. Zulkarnaev, N. M. Fominykh, Z. B. Kardanakhishvili, E. V. Strugailo, А. В. Ватазин, А. Б. Зулькарнаев, Н. М. Фоминых, З. Б. Карданахишвили, Е. В. Стругайло
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 20, № 4 (2018); 44-53 ; Вестник трансплантологии и искусственных органов; Том 20, № 4 (2018); 44-53 ; 1995-1191 ; 10.15825/1995-1191-2018-4
Θεματικοί όροι: центральный венозный катетер, hemodialysis, arteriovenous fistula, synthetic vascular graft, central venous catheter, гемодиализ, артериовенозная фистула, синтетический сосудистый протез
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/949/753; Arhuidese IJ, Obeid T, Hicks C, Qazi U, Botchey I, Zarkowsky DS et al. Vascular access modifies the protective effect of obesity on survival in hemodialysis patients. Surgery. 2015; 158 (6): 1628–1634. PMID: 26126794. doi:10.1016/j.surg.2015.04.036.; Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015; 150 (5): 441–448. PMID: 25738981. doi:10.1001/jamasurg.2014.3484.; Zhang JC, AlJaishi AA, Na Y, de Sa E, Moist LM. Association between vascular access type and patient mortality among elderly patients on hemodialysis in Canada. Hemodial Int. 2014; 18 (3): 616–624. PMID: 24636659. doi:10.1111/hdi.12151.; Томилина НА, Андрусев АМ, Перегудова НГ, Шинкарев МБ. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010–2015 гг. Отчет по данным общероссийского регистра заместительной почечной терапии Российского диализного общества, часть первая. Нефрология и диализ. 2017; 19 (4, приложение): 1–95. doi:10.28996/1680-4422-2017-4suppl-1-95. Tomilina NA, Andrusev AM, Peregudova NG, Shinkarev MB. Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2010–2015. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists «Russian Dialysis Society», Part 1. Nefrologiya i dializ [Nephrology and dialysis]. 2017; 19 (4, supplement): 1–95. [In Russ, English abstract]. doi:10.28996/1680-4422-2017-4suppl-1-95.; ERA-EDTA-reg.org [Internet]. European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015. 2017; Available at: https://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2015.pdf.; USRDS.org [Internet]. United States Renal Data System. 2016 USRDS annual data report. Volume 2 – Endstage Renal Disease (ESRD) in the United States: 1 · Incidence, Prevalence, Patient Characteristics, and Treatment Modalities 2016; Available at: https://www.usrds.org/2016/view/Default.aspx.; ANZDATA.org.au [Internet]. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). Annual Data Report 2016. 2016; Available at: http://www.anzdata.org.au/v1/report_2016.html.; Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T et al. Annual Dialysis Data Report 2014, JSDT Renal Data Registry (JRDR). Renal Replacement Therapy. 2017; 3: 18. doi:10.1186/s41100-017-0097-8.; van Walraven C, Manuel DG, Knoll G. Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis. 2014; 63 (3): 491–499. PMID: 24210591. doi:10.1053/j.ajkd.2013.09.011.; Vigneau C, Kolko A, Stengel B, Jacquelinet C, Landais P, Rieu P et al. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry. Nephrol Ther. 2017; 13 (4): 228–235. PMID: 28161264 doi:10.1016/j.nephro.2016.07.453.; Neild GH. Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol. 2017; 32 (2): 243–248. PMID: 27115888. doi:10.1007/s00467-016-3383-8.; Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant. 2006; 21 (3): 721–728. PMID: 16311264 doi:10.1093/ndt/gfi281.; Fassiadis N, Morsy M, Siva M, Marsh JE, Makanjuola AD, Chemla ES. Does the surgeon’s experience impact on radiocephalic fistula patency rates? Semin Dial. 2007; 20 (5): 455–457. PMID: 17897253. doi:10.1111/j.1525-139X.2007.00310.x.; Moist LM, Lee TC, Lok CE, AlJaishi A, Xi W, Campbell V et al. Education in vascular access. Semin Dial. 2013; 26 (2): 148–153. PMID: 23432319. doi:10.1111/sdi.12055.; Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg. 2008; 247 (5): 885–891. PMID: 18438128 doi:10.1097/SLA.0b013e31816c4044.; Hakim RM, Himmelfarb J. Hemodialysis access failure: a call to action – revisited. Kidney Int. 2009; 76 (10): 1040–1048. PMID: 19710629. doi:10.1038/ki.2009.318.; Nguyen VD, Griffith CN, Reus J, Barclay C, Alford S, Treat L et al. Successful AV fistula creation does not lead to higher catheter use: the experience by the Northwest Renal Network 16 Vascular Access Quality Improvement Program. Four years follow-up. J Vasc Access. 2008; 9 (4): 260–268. PMID: 19085896; Premužić V, Tomašević B, Eržen G, Makar K, BrunettaGavranić B, Francetić I et al. Temporary and permanent central venous catheters for hemodialysis. Acta Med Croatica. 2014; 68 (2): 167–174. PMID: 26012155.; Zulkarnaev A, Vatazin A, Yankovoy A, Fominikh N, Kardanahishvili Z. Preventive surgery for hemodialysis vascular access saving. J Vasc Access. 2017; 18 (Suppl. 2): S21. doi:10.5301/jva.5000726.; Wadełek J. Haemodialysis catheters. Anestezjol Intens Ter. 2010; 42 (4): 213–217. PMID: 21252839.; Gupta V, Yassin MH. Infection and hemodialysis access: an updated review. Infect Disord Drug Targets. 2013; 13 (3): 196–205. PMID: 24001331.; Silva TN, de Marchi D, Mendes ML, Barretti P, Ponce D. Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review. Hemodial Int. 2014; 18 (1): 15–23. PMID: 23944971. doi:10.1111/hdi.12071.; Hoggard J, Saad T, Schon D, Vesely TM, Royer T. Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial. 2008; 21 (2): 186–191. PMID: 18364015 doi:10.1111/j.1525-139X.2008.00421.x.; Hayes W, Hothi DK. Intradialytic hypotension. Pediatr Nephrol. 2011; 26 (6): 867–879. PMID: 20967553. doi:10.1007/s00467-010-1661-4.; Mc Causland FR, Brunelli SM, Waikar SS. Dialysis dose and intradialytic hypotension: results from the HEMO study. Am J Nephrol. 2013; 38 (5): 388–396. PMID: 24192428. doi:10.1159/000355958.; Aronoff GR. The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotension. Semin Dial. 2017; 30 (6): 489–491. PMID: 28666075. doi:10.1111/sdi.12625.; Van Buren PN, Inrig JK. Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin Dial. 2017; 30 (6): 545–552. PMID: 28666072. doi:10.1111/sdi.12631.; Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011; 22 (8): 1526–1533. PMID: 21803971. doi:10.1681/ASN.2010101119.; Sands JJ, Usvyat LA, Sullivan T, Segal JH, Zabetakis P, Kotanko P et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014; 18 (2): 415–422. PMID: 24467830. doi:10.1111/hdi.12138.; Manne V, Vaddi SP, Reddy VB, Dayapule S. Factors influencing patency of Brescia-Cimino arteriovenous fistulas in hemodialysis patients. Saudi J Kidney Dis Transpl. 2017; 28 (2): 313–317. PMID: 28352013. doi:10.4103/1319-2442.202759.; Sherman RA, Kapoian T. Intradialytic hypotension strikes again. J Am Soc Nephrol. 2011; 22 (8): 1396–1398. PMID: 21757768. doi:10.1681/ASN.2011060541.; Шалягин ЮД, Швецов МЮ, Боярский СГ, Шилов ЕМ. Распространенность снижения скорости клубочковой фильтрации как маркера хронической болезни почек у пациентов Клиники нефрологии, внутренних и профессиональных болезней им. Е.М. Тареева Московской медицинской академии им. И.М. Сеченова. Нефрология и диализ. 2009; 11 (4): 336–337. Shalyagin YD, Shvetsov MYu, Boyarsky SG, Shilov EM. The prevalence of decreased glomerular filtration rate as a marker of chronic kidney disease in patients of the Nephrology Clinic of Internal Medicine and Occupational Diseases named after E.M. Tareev and Sechenov Moscow Medical Academy. Nefrologiya i dializ [Nephrology and dialysis]. 2009; 11 (4): 336–337. [In Russ].; Нагайцева СС, Шалягин ЮД, Швецов МЮ, Пягай НЛ, Иванова ЕС, Шилов ЕМ. Оценка альбуминурии методом тест-полосок с целью раннего выявления хронической болезни почек у лиц с разной степенью риска (опыт центров здоровья Московской области). Терапевтический архив. 2013; 85 (6): 38–43. Na gai tse va SS, Shaliagin YuD, Shvetsov MYu, Piagai NL, Ivanova ES, Shilov EM. Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region). Terapevticheskiy arkhiv (Therapeutic archive). 2013; 85 (6): 38–43. [In Russ, English abstract].; https://journal.transpl.ru/vtio/article/view/949
-
9Academic Journal
Συγγραφείς: I. Kurmukov, AM Pronina, ShR Kashiya, OA Obuhova
Πηγή: Клиническая онкогематология, Vol 8, Iss 4 (2015)
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, венозный доступ, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, периферически имплантируемый центральный венозный катетер (PICC), венепункция под ультразвуковым контролем, RC254-282
-
10Academic Journal
Πηγή: Клиническая онкогематология, Vol 7, Iss 2 (2014)
Θεματικοί όροι: PICC, ЦВК, периферически имплантируемый центральный венозный катетер, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Σύνδεσμος πρόσβασης: https://doaj.org/article/f8d1af938f6b47ad931d1fb5c5488ea4
-
11Academic Journal
Συγγραφείς: Boronina, L. G., Samatova, E. V., Kukushkina, M. P., Blinova, S. M., Ustyugova, S. S., Panova, S. A., Боронина, Л. Г., Саматова, Е. В., Кукушкина, М. П., Блинова, С. М., Устюгова, С. С., Панова, С. А.
Πηγή: Вестник Уральского государственного медицинского университета
Θεματικοί όροι: CENTRAL VENOUS CATHETER, CATHETER-ASSOCIATED INFECTIONS, MICROBIOLOGICAL DIAGNOSTICS, BLOODSTREAM INFECTIONS, ЦЕНТРАЛЬНЫЙ ВЕНОЗНЫЙ КАТЕТЕР, КАТЕТЕР-АССОЦИИРОВАННЫЕ ИНФЕКЦИИ, МИКРОБИОЛОГИЧЕСКАЯ ДИАГНОСТИКА, ИНФЕКЦИИ КРОВОТОКА
Περιγραφή αρχείου: application/pdf
Relation: Вестник Уральского государственного медицинского университета. 2017. №1; http://elib.usma.ru/handle/usma/343
Διαθεσιμότητα: http://elib.usma.ru/handle/usma/343
-
12Academic Journal
Συγγραφείς: Vatazin A.V., Zulkarnaev A.B., Fominykh N.M., Kardanakhishvili Z.B., Strugaylo E.V.
Πηγή: Almanac of Clinical Medicine; Vol 45, No 7 (2017); 526-534 ; Альманах клинической медицины; Vol 45, No 7 (2017); 526-534 ; 2587-9294 ; 2072-0505 ; 10.18786/2072-0505-2017-45-7
Θεματικοί όροι: chronic kidney disease, hemodialysis, vascular access, arteriovenous fistula, central venous catheter, registry, хроническая болезнь почек, гемодиализ, сосудистый доступ, артериовенозная фистула, центральный венозный катетер, регистр
Περιγραφή αρχείου: application/pdf
Relation: https://almclinmed.ru/jour/article/view/638/610; https://almclinmed.ru/jour/article/downloadSuppFile/638/774; https://almclinmed.ru/jour/article/downloadSuppFile/638/775; https://almclinmed.ru/jour/article/downloadSuppFile/638/776; https://almclinmed.ru/jour/article/downloadSuppFile/638/777; https://almclinmed.ru/jour/article/downloadSuppFile/638/778; https://almclinmed.ru/jour/article/downloadSuppFile/638/779; https://almclinmed.ru/jour/article/downloadSuppFile/638/780; https://almclinmed.ru/jour/article/view/638
-
13Academic Journal
Συγγραφείς: A. A. Yatsenko, T. I. Petrenko, P. N. Filimonov
Πηγή: Туберкулез и болезни лёгких, Vol 95, Iss 8, Pp 35-40 (2017)
Θεματικοί όροι: туберкулез, тромбоэмболия легочных артерий, тромбоз глубоких вен, легочная хирургия, тест тромбодинамики, тромбоэластометрия, центральный венозный катетер, генетические полиморфизмы, Diseases of the respiratory system, RC705-779
Relation: https://www.tibl-journal.com/jour/article/view/1032; https://doaj.org/toc/2075-1230; https://doaj.org/toc/2542-1506; https://doaj.org/article/b55c9c731db64d7dae02ea1b56c866c1
-
14Academic Journal
-
15Academic Journal
Θεματικοί όροι: болезнь Виллебранда, long-term vascular access, peripherally inserted central catheter, hemophilia, периферически имплантируемый центральный венозный катетер, порт, устройство, von Willebrand disease, port, гемофилия, 3. Good health
Σύνδεσμος πρόσβασης: https://cyberleninka.ru/article/n/obespechenie-dolgosrochnogo-sosudistogo-dostupa-u-bolnyh-gemofiliey
-
16Academic Journal
Συγγραφείς: Anikin, І. А.
Πηγή: Zaporozhye Medical Journal; No. 5 (2016): Zaporozhye Medical Journal ; Запорожский медицинский журнал; № 5 (2016): Запорізький медичний журнал ; Запорізький медичний журнал; № 5 (2016): Запорізький медичний журнал ; 2310-1210 ; 2306-4145
Θεματικοί όροι: Central Venous Catheter, Newborn, Catheter-Associated Infection, центральный венозный катетер, новорождённый, катетер-ассоциированная инфекция, центральний венозний катетер, новонароджений, катетер-асоційована інфекція
Περιγραφή αρχείου: application/pdf
Relation: http://zmj.zsmu.edu.ua/article/view/82621/78782; http://zmj.zsmu.edu.ua/article/view/82621
Διαθεσιμότητα: http://zmj.zsmu.edu.ua/article/view/82621
-
17Academic Journal
-
18Academic Journal
Συγγραφείς: N. A. Grigoryeva, A. S. Ulanova, V. A. Pyatkov, I. A. Turabov, Н. А. Григорьева, А. С. Уланова, В. А. Пятков, И. А. Турабов
Πηγή: Russian Journal of Pediatric Hematology and Oncology; Том 2, № 2 (2015); 93-98 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 2, № 2 (2015); 93-98 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2015-2-2
Θεματικοί όροι: детская больница, oncologic diseases, central venous catheter, fully implanted device, catheter associated complications, children, children,s hospital, опухоль, онкологические заболевания, центральный венозный катетер, полностью имплантируемое устройство, катетер-ассоциированные осложнения, дети
Περιγραφή αρχείου: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/108/104; Рыков М. Ю., Гьокова Е. В., Дзампаев А. З. и др. Имплантируемая порт-система как оптимальный венозный доступ в детской онкологии. Онкопедиатрия 2014;1:25–31. [Rykov M. Yu., Gyokova E. V., Dzampaev A. Z. et al. Implantable port-system – the optimal venous access at pediatric oncology. Onkopediatriya = Oncopediatrics 2014; 1:25–31. (In Russ.)].; Закиров И. И., Кумирова Э. В. Современное состояние проблемы долговременного венозного доступа в педиатрии (обзор литературы). Детская онкология 2006;2–3:11–5. [Zakirov I. I., Kumirova E. V. Long-term venous access: the current state of the problem. Detskaya onkologiya = Pediatric Oncology 2006; 2–3:11–5. (In Russ.)].; Nam S. H., Kim D. Y., Kim S. C., Kim I. K. Complications and risk factors; of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer 2010;54(4):546–51.; Рыков М. Ю., Гьокова Е. В., Сусулева Н. А., Поляков В. Г. Профилактика катетер- ассоциированных инфекций в онкопедиатрии. Злокачественные опухоли 2013;2:71–8. [Rykov M. Yu., Gyokova E. V., Susuleva N. A., Polyakov V. G. Prevention of catheter-related infections in oncopediatria. Zlokachestvennye opukholi = Malignant Tumours 2013;2:71–8.; (In Russ.)].; Буйденок Ю.В., Мещеряков А. А., Бредер В. В. и др. Имплантируемые инфузионные системы для длительного венозного доступа в онкологии. Вестник Московского онкологического общества 2010;2(565):2–4. [Buidenok Yu. V., Meshceryakov A. A., Breder V. V. et al. Implanted port-systems for long-term intravenous access in patients with cancer. Vestnik Moskovskogo onkologicheskogo obschestva = Bulletin of the Moscow Cancer Society 2010;2(565):2–4. (In Russ.)].; Рыков М. Ю., Поляков В. Г. Имплантируемые венозные порт-системы в онкопедиатрии. ФГБУ РОНЦ им. Н. Н. Блохина. СПб., 2013. [Rykov M. Yu., Polyakov V. G. Implanted venous port-system in oncopediatria. N. N. Blokhin Russian Cancer Research Center. Saint-Petersburg, 2013.; Туробова Т. В., Турабов И. А., Волыхин И. В. Использование полностью имплантируемых устройств для полихимиотерапии и инфузионной терапии; в детской онкологии. Детская онкология 2009;3–4:73–7. [Turobova T. V., Turabov I. A., Volykhin I. V. Use completely implanted devices for polychemotherapy and infusion therapy in children,s oncology. Detskaya onkologiya = Pediatric Oncology 2009; 3–4:73–7. (In Russ.)].; Зуфаров М. М., Искандаров Ф. А., Илюхин В. В. и др. Транскатетерное удаление инородных тел из полостей сердца и магистральных сосудов. Материалы конференции в Республиканском специализированном центре хирургии им. акад. В. Вахидова. Ташкент, 2004. С. 49–50. [Zufarov M. M., Iskandarov F. A., Ilyukhin V. V. et al. Transcatheter removal of foreign bodies from the cavities of the heart and great vessels. Materials of the conference in the Republican Specialized Surgery Center named after acad. V. Vakhidov. Tashkent, 2004. Pp. 49–50. (In Russ.)].; https://journal.nodgo.org/jour/article/view/108
-
19Academic Journal
Συγγραφείς: ПРОНИНА А.М., КУРМУКОВ И.А., ОБУХОВА О.А., КАШИЯ Ш.Р.
Περιγραφή αρχείου: text/html
-
20Academic Journal
Συγγραφείς: КОЗЕЛЬ Ю.Ю., ТУМАНЯН С.В., СЕМИЛЕТКИНА Е.Ю., КУЗНЕЦОВ С.А., СТАРЖЕЦКАЯ М.В., МКРТЧЯН Г.А.
Θεματικοί όροι: ОСЛОЖНЕНИЯ, ДЕТСКАЯ ОНКОЛОГИЯ, ВЕНОЗНЫЙ ПОРТ, ПЕРИФЕРИЧЕСКИ ИМПЛАНТИРУЕМЫЙ ЦЕНТРАЛЬНЫЙ ВЕНОЗНЫЙ КАТЕТЕР (PICC), ПОДКЛЮЧИЧНЫЙ И БЕДРЕННЫЙ КАТЕТЕРЫ, PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC)
Περιγραφή αρχείου: text/html
